Delivery Order SPE2DB22D3004-SPE2DB25FPB29

Award Date 1/10/25
Potential Completion Date 2/3/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,024.14, is a delivery order with a firm fixed price pricing type and an ultimate completion date of January 6, 2025. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS, a pharmaceutical product. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,637.74, is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS to support military healthcare programs. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.65 firm fixed-price delivery order contract is for 4566307024 ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, as well as a separate...
This federal contract award, valued at $10,460.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of November 27, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.83 Firm Fixed Price Delivery Order contract is for the supply of 4566615955 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.71 firm fixed-price delivery order, which is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, is for the supply of 4566554891 ! ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract, which has a completion date of November 27, 2024,...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,236.51 firm-fixed-price delivery order contract has a completion date of December 18, 2024. The contract covers the provision of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $2,108.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a medical product, with a completion date of November 27, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,835.45 firm fixed-price delivery order is for the supply of a pharmaceutical product called "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." The contract has an ultimate completion date of December 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,422.60 firm-fixed-price delivery order is for the supply of the drug product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPB29
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,510.68, is a Firm Fixed Price Delivery Order for the supply of ZYMFENTRA 120 MG/ML PEN KITS. The contract has a completion date of February 3, 2025 and was awarded on January 10, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 4/13/25, 12:48 AM